Belma Alispahic

Belma Alispahic Email and Phone Number

Enterprise Account Executive @ Katalyze AI
Frankfurt, HE, DE
Belma Alispahic's Location
Helsinki, Uusimaa, Finland, Finland
About Belma Alispahic

Are you driving innovation in bioprocessing and looking to amplify your impact? Let's make it happen together.I'm Belma Alispahić, Co-Founder and Chief Scientific Officer at AnalysisMode. I lead our mission to transform bioprocess development through AI. Our AI-powered platform, SimCell, is designed to unlock the full potential of your processes—accelerating efficiency, precision, and outcomes.What Can You Expect?At AnalysisMode, we bridge the gap between cutting-edge AI and biopharma's most pressing challenges. I collaborate directly with industry leaders to integrate AI into workflows, reducing time-to-market and enhancing production capabilities. Whether it's optimizing upstream processes or designing experiments, I'm passionate about ensuring SimCell delivers tangible value to your operations.Beyond the LabWhen I'm not advancing bioprocess development, I'm deeply engaged in discussions about start-ups, community building, strategy, and partnerships. I believe the future is shaped through collaboration and continuously exploring ways to drive meaningful change. From mentoring through the Bosnia and Herzegovina Futures Foundation (BHFF) to connecting with fellow innovators, my goal is to inspire and be inspired.If you're ready to explore the future of AI in bioprocessing—or simply want to talk strategy and innovation—let's connect.

Belma Alispahic's Current Company Details
Katalyze AI

Katalyze Ai

View
Enterprise Account Executive
Frankfurt, HE, DE
Website:
katalyzeai.com
Employees:
18
Belma Alispahic Work Experience Details
  • Katalyze Ai
    Enterprise Account Executive
    Katalyze Ai
    Frankfurt, He, De
  • Analysismode
    Chief Scientific Officer
    Analysismode
    Helsinki, Fi
  • Analysismode
    Chief Scientific Officer
    Analysismode Mar 2024 - Present
  • Analysismode
    Head Of Business Development
    Analysismode Oct 2021 - Mar 2024
    Finland
    As the Head of Business Development and Co-Founder at AnalysisMode, I play a pivotal role in shaping the business's direction and propelling AI to the forefront of bioprocessing. My journey is marked by a fervent commitment to innovation, a strong belief in AI's transformative potential, and a focus on bridging the gap between science and advanced technologies.Key Responsibilities:1. Strategic Business Development: I'm the driving force behind expanding our horizons in the… Show more As the Head of Business Development and Co-Founder at AnalysisMode, I play a pivotal role in shaping the business's direction and propelling AI to the forefront of bioprocessing. My journey is marked by a fervent commitment to innovation, a strong belief in AI's transformative potential, and a focus on bridging the gap between science and advanced technologies.Key Responsibilities:1. Strategic Business Development: I'm the driving force behind expanding our horizons in the bioprocessing industry, identifying new opportunities, and ensuring our growth aligns with our vision.2. Partnerships and Alliances: Creating meaningful partnerships with biopharmaceutical companies, CDMOs, equipment manufacturers, and academia is a core focus, fostering an ecosystem of collaboration.3. AI-Powered Bioprocessing: At AnalysisMode, we've put AI at the heart of bioprocessing. My role is to drive the adoption of AI solutions, bringing about a transformative shift in bioprocess modeling.4. Marketing and Branding: Amplifying our presence in the biopharma community through strategic marketing channels and establishing SimCell as a trusted brand.5. Lean and Value Proposition: Applying my expertise to identify customer needs and translate them into product development strategies.6. Networking and Industry Engagement: Engaging actively in the biopharmaceutical ecosystem, I've leveraged platforms like LinkedIn to expand our network and drive the AI revolution in bioprocessing.Impactful AI Integration in Bioprocessing:The heart of my role as the Co-Founder of AnalysisMode is to make AI accessible for the biopharma industry, transforming the landscape of bioprocessing. AI integration has opened doors to unprecedented insights, efficiency, and innovation. SimCell, an AI-driven tool we've developed, accelerates bioprocessing, reduces costs, and empowers scientists in their quest for advanced therapies Show less
  • Analysismode
    Research Collaborator
    Analysismode Jun 2021 - Oct 2021
  • Futures Leaders Summit
    Partnerships And Sponsorship Team Lead
    Futures Leaders Summit Jun 2023 - Jan 2024
    Bosnia And Herzegovina
  • Bosnia & Herzegovina Futures Foundation
    Partnerships Team Lead
    Bosnia & Herzegovina Futures Foundation Dec 2022 - Jan 2024
    Bosnia And Herzegovina
  • Futures Leaders Summit
    Partnerships And Sponsorships Team Lead
    Futures Leaders Summit Aug 2022 - Dec 2022
    Futures Leaders Summit (FLS) gathers future STEM leaders from Bosnia and Herzegovina. By establishing an event that will annually gather prospective change makers in the field of STEM, we aim to create a strong network that will change the way we perceive the industry and the future of our country's development.My responsibilities included: - strategy for sponsorships and partnerships - execution and implementation- organizing and coordinating team activities -… Show more Futures Leaders Summit (FLS) gathers future STEM leaders from Bosnia and Herzegovina. By establishing an event that will annually gather prospective change makers in the field of STEM, we aim to create a strong network that will change the way we perceive the industry and the future of our country's development.My responsibilities included: - strategy for sponsorships and partnerships - execution and implementation- organizing and coordinating team activities - fundraising - communication with sponsors Show less
  • Boston Genetics
    Genetic Curation Specialist
    Boston Genetics Feb 2020 - Oct 2021
    Variant analyst helping clinicians prevent disorders by classifying DNA variants using ACMG criteria. • Synthesized and presented complex information in brief but clear summaries • Analyzed variant-related published scientific literature, genetic and population databases (NCBI, ClinVar, HGMD, ClinGen, OMIM, gnomAD, etc.)• Analyzed variants using Alamut tools (splicing predictions, NMD predictions , UCSC db etc.) and IGV • Wrote customized result reports• Assigned ACMG… Show more Variant analyst helping clinicians prevent disorders by classifying DNA variants using ACMG criteria. • Synthesized and presented complex information in brief but clear summaries • Analyzed variant-related published scientific literature, genetic and population databases (NCBI, ClinVar, HGMD, ClinGen, OMIM, gnomAD, etc.)• Analyzed variants using Alamut tools (splicing predictions, NMD predictions , UCSC db etc.) and IGV • Wrote customized result reports• Assigned ACMG criteria to collected evidence • Improved analytical skills by critically reading scientific publications • Improved detail orientation by remembering and applying SOPs for different types of variants • Improved critical thinking by making decisions based on fewer evidence Show less
  • Uppsala University
    Master Thesis Project
    Uppsala University Jan 2019 - Sep 2019
    Uppsala, Sweden
    Thesis Title: Computational assisted design of antagonists of the CB1 cannabinoid receptor with peripheral selectivity • Performed structure-based analysis of 7 different chemical series; Analyzed potential peripherally selective drugs • Receptor modelling: Prepared two different starting CB1 receptor structures using PDBdb and PyMol alignment tools • Carried out ligand docking on CB1-Rimonabnat minimized structures using Schrödinger Tools: Maestro’s Protein Preparation Wizard… Show more Thesis Title: Computational assisted design of antagonists of the CB1 cannabinoid receptor with peripheral selectivity • Performed structure-based analysis of 7 different chemical series; Analyzed potential peripherally selective drugs • Receptor modelling: Prepared two different starting CB1 receptor structures using PDBdb and PyMol alignment tools • Carried out ligand docking on CB1-Rimonabnat minimized structures using Schrödinger Tools: Maestro’s Protein Preparation Wizard, 2D Sketcher, LigPrep and GLIDE’s standard precision: Docking protocol performed on all 40 compounds on 2 xtal structures • Analyzed structure-affinity relationships of CB1 and docked ligands • Run MD (molecular dynamics) analysis: 3 runs of 50 ns on two selected chemical series; Analysis performed using GROMACS: RMSF on ligand, RMSD on backbone and ligand, Ligand-protein hydrogen bond analysisSupervisor: Hugo Gutierrez de Teran; Co-supervisor: Willem Jespers Show less
  • Preventia Assistans Ab
    Nursery Assistant
    Preventia Assistans Ab Jan 2018 - Aug 2019
    Uppsala, Sweden
    Taking personal care of a person with special needs• Prepared therapy and meals • Assisted the patient in his daily routines • Improved my intuition and stress response by being responsible for following the breathing and oxygen level of the patient • Worked in a multicultural environment where I had to communicate with non English speaking coworkers to coordinate activities
  • Uppsala University
    Research Trainee
    Uppsala University Jun 2018 - Oct 2018
    Uppsala, Sweden
    Computational-assisted ligand design: novel adenosine A2B receptor antagonists as anti-cancer drugsThe series was analyzed with one of the most exhaustive free energy perturbation studies on a GPCR, obtaining an accurate model of the structure–activity relationship of this chemotype. In this study, a correlation was found between FEP predictions and the structure-affinity relationship of the dataset. The results will be used in the assessment of the synthesis of novel derivatives of A2B… Show more Computational-assisted ligand design: novel adenosine A2B receptor antagonists as anti-cancer drugsThe series was analyzed with one of the most exhaustive free energy perturbation studies on a GPCR, obtaining an accurate model of the structure–activity relationship of this chemotype. In this study, a correlation was found between FEP predictions and the structure-affinity relationship of the dataset. The results will be used in the assessment of the synthesis of novel derivatives of A2B antagonists, which will be tested for their effect as anti proliferative compounds in certain cancer types. • Performed extensive FEP calculations on different A2B antagonist series • Tested different FEP protocols by manipulating the protocol Publication: https://pubs.acs.org/doi/abs/10.1021/acs.jmedchem.0c01431Supervisor: Hugo Gutierrez de Teran; Co-supervisor: Willem Jespers Show less
  • Bibo Global Opportunity
    Online English Teacher
    Bibo Global Opportunity Sep 2016 - Sep 2017
    -Demonstrated organisational skills in leading lesson flow and curriculum design-Rated with 4.8/5 from student feedback, indicating a high ability to transfer knowledge and demonstrate empathy towards different cultural backgrounds and learning styles
  • Prolab Sarajevo
    Laboratory Assistant
    Prolab Sarajevo Aug 2015 - Sep 2015
    Bosnia And Herzegovina
    Performed urine sedimentation and analysis, blood analysis, peripheral blood analysis, semen analysis, tumor and hormone markers
  • Opća Bolnica Bugojno
    Laboratory Assistant
    Opća Bolnica Bugojno Jul 2014 - Aug 2014
    Bosnia And Herzegovina
    Performed urine sedimentation and analysis, blood analysis, peripheral blood analysis, tumor and hormone markers

Belma Alispahic Skills

Research Laboratory Skills Bioinformatics Molecular Biology Programming Genetics Biochemistry Communication Public Speaking Genomics Microsoft Office Computational Biology Microsoft Excel Human Genetics Forensic Analysis Ucsc Genome Browser Maestro Molecular Dynamics Polymerase Chain Reaction Biotechnology Reverse Transcription Polymerase Chain Reaction Stress Management Protein Protein Interactions Teaching Multitasking Pymol Bacterial Transformation Bacterial Cell Culture Protein Folding Pcr Primer Design Protein Structure Synthetic Biology Biomedical Sciences Multiplex Pcr Mathlab Ligand Design Drug Discovery Molecular Modeling Computational Chemistry Drug Design Cheminformatics

Belma Alispahic Education Details

Frequently Asked Questions about Belma Alispahic

What company does Belma Alispahic work for?

Belma Alispahic works for Katalyze Ai

What is Belma Alispahic's role at the current company?

Belma Alispahic's current role is Enterprise Account Executive.

What schools did Belma Alispahic attend?

Belma Alispahic attended Uppsala University, International Burch University, Sarajevo College.

What are some of Belma Alispahic's interests?

Belma Alispahic has interest in Science And Technology.

What skills is Belma Alispahic known for?

Belma Alispahic has skills like Research, Laboratory Skills, Bioinformatics, Molecular Biology, Programming, Genetics, Biochemistry, Communication, Public Speaking, Genomics, Microsoft Office, Computational Biology.

Not the Belma Alispahic you were looking for?

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant

Download 750 million emails and 100 million phone numbers

Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.